Commission Regulation (EU) 2019/1966 [Commission Regulation (EU) 2019/1966 of 27 November 2019 amending and correcting Annexes II, III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (OJ L 307, 28.11.2019, p. 15).], that was adopted to uniformly implement the prohibition of substances classified as CMR, pursuant to Regulation (EC) No 1272/2008, by Commission Regulation (EU) 2018/1480 [Commission Regulation (EU) 2018/1480 of 4 October 2018 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures and correcting Commission Regulation (EU) 2017/776 (OJ L 251, 5.10.2018, p. 1).], introduced changes to entry 98 of Annex III to Regulation (EC) No 1223/2009 with regard to the substance benzoic acid, 2-hydroxy- (INCI name: salicylic acid). In order to fully align those changes with the conclusion of the original SCCS opinion [SCCS (Scientific Committee on Consumer Safety), Opinion on salicylic acid, Corrigendum of 20-21 June 2019, SCCS/1601/18.], it is appropriate to authorise the use of that substance, for purposes other than preservative function, in body lotion, eye shadow, mascara, eyeliner, lipstick and roll-on deodorant in a concentration of up to 0,5 %. Entry 98 of Annex III to Regulation (EC) No 1223/2009 should therefore be amended accordingly.
Recital 12, Regulation (EU) 2021/850
In forcesince 26 May 2021